Injectable Drug Delivery Devices Market (2026 - 2033)

Size, Share & Trends Analysis Report By Product (Injectors, Pen), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology, Obesity, Diabetes Mellitus), By End Use, By Region, And Segment Forecasts

Market Segmentation

Injectable Drug Delivery Devices Product Outlook (Revenue, USD Billion, Volume, Units, 2021 – 2033)
- Injectors
  - GLP-1 Agonists
  - Hormone Therapies
  - Biologics
  - Others
- Pen
  - GLP-1 Agonists
  - Insulin
  - Hormone Therapies
  - Others
Injectable Drug Delivery Devices Therapeutic Use Outlook (Revenue, USD Billion, Volume, Units, 2021 – 2033)
- Autoimmune Disorders
- Hormonal Disorders
- Oncology
- Obesity
- Diabetes Mellitus
- Others
Injectable Drug Delivery Devices End Use Outlook (Volume Units; Revenue, USD Billion, 2021 – 2033)
- Hospitals
- Homecare Settings
- Others
Injectable Drug Delivery Devices Regional Outlook (Volume Units; Revenue, USD Billion, 2021 – 2033)
- North America
  - North America Injectable Drug Delivery Devices Market, By Product
    - Injectors
      - GLP-1 Agonists
      - Hormone Therapies
      - Biologics
      - Others
    - Pen
      - GLP-1 Agonists
      - Insulin
      - Hormone Therapies
      - Others
  - North America Injectable Drug Delivery Devices Market, By Therapeutic Use
    - Autoimmune Disorders
    - Hormonal Disorders
    - Oncology
    - Obesity
    - Diabetes Mellitus
    - Others
  - North America Injectable Drug Delivery Devices Market, By End Use
    - Hospitals
    - Homecare Settings
    - Others
  - U.S.
    - U.S. Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - U.S. Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - U.S. Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Canada
    - Canada Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Canada Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Canada Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Mexico
    - Mexico Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Mexico Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Mexico Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
- Europe
  - Europe Injectable Drug Delivery Devices Market, By Product
    - Injectors
      - GLP-1 Agonists
      - Hormone Therapies
      - Biologics
      - Others
    - Pen
      - GLP-1 Agonists
      - Insulin
      - Hormone Therapies
      - Others
  - Europe Injectable Drug Delivery Devices Market, By Therapeutic Use
    - Autoimmune Disorders
    - Hormonal Disorders
    - Oncology
    - Obesity
    - Diabetes Mellitus
    - Others
  - Europe Injectable Drug Delivery Devices Market, By End Use
    - Hospitals
    - Homecare Settings
    - Others
  - UK
    - UK Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - UK Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - UK Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Germany
    - Germany Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Germany Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Germany Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - France
    - France Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - France Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - France Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Italy
    - Italy Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Italy Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Italy Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Spain
    - Spain Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Spain Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Spain Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Norway
    - Norway Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Norway Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Norway Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Sweden
    - Sweden Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Sweden Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Sweden Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Denmark
    - Denmark Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Denmark Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Denmark Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
- Asia
  - Asia Injectable Drug Delivery Devices Market, By Product
    - Injectors
      - GLP-1 Agonists
      - Hormone Therapies
      - Biologics
      - Others
    - Pen
      - GLP-1 Agonists
      - Insulin
      - Hormone Therapies
      - Others
  - Asia Injectable Drug Delivery Devices Market, By Therapeutic Use
    - Autoimmune Disorders
    - Hormonal Disorders
    - Oncology
    - Obesity
    - Diabetes Mellitus
    - Others
  - Asia Injectable Drug Delivery Devices Market, By End Use
    - Hospitals
    - Homecare Settings
    - Others
  - China
    - China Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - China Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - China Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Japan
    - Japan Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Japan Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Japan Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - India
    - India Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - India Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - India Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Thailand
    - Thailand Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Thailand Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Thailand Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - South Korea
    - South Korea Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - South Korea Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - South Korea Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Saudi Arabia
    - Saudi Arabia Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Saudi Arabia Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Saudi Arabia Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - UAE
    - UAE Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - UAE Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - UAE Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others
  - Kuwait
    - Kuwait Injectable Drug Delivery Devices Market, By Product
      - Injectors
        
        GLP-1 Agonists
        
        Hormone Therapies
        
        Biologics
        
        Others
      - Pen
        
        GLP-1 Agonists
        
        Insulin
        
        Hormone Therapies
        
        Others
    - Kuwait Injectable Drug Delivery Devices Market, By Therapeutic Use
      - Autoimmune Disorders
      - Hormonal Disorders
      - Oncology
      - Obesity
      - Diabetes Mellitus
      - Others
    - Kuwait Injectable Drug Delivery Devices Market, By End Use
      - Hospitals
      - Homecare Settings
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments